The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

Entries from August 2019

E45: TNF or TCZ or ABA or RTX: Real World Data for RA

August 29th, 2019 · Comments

This week I tackle an interesting cohort study that Jack Cush (@RheumNow) mentioned in his podcast.  It's a nice opportunity to discuss bDMARDs in the "real world" (AKA Sweden).  Follow me @ebrheum and let me know what you think of the episode! 

Tags: DefaultTag

E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis

August 15th, 2019 · Comments

Finally got around to tackling the JAKi this week.  I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo.  I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum! 

Tags: DefaultTag

E43: Tofacitinib for MDA5 Amyopathic Dermatomyositis ILD

August 8th, 2019 · Comments

Back this week to discuss an interesting paper in the NEJM.  Lots of interesting issues, most notably historical controls and their limitations.  Find all my work at ebrheum.com! 

Tags: DefaultTag

Play this podcast on Podbean App